Genetic Variation and Neuroimaging Measures in Alzheimer Disease
Open accessAbstract
OBJECTIVE: To investigate whether genome-wide association study (GWAS)-validated and GWAS-promising candidate loci influence magnetic resonance imaging measures and clinical Alzheimer's disease (AD) status. DESIGN: Multicenter case-control study of genetic and neuroimaging data from the Alzheimer's Disease Neuroimaging Initiative. SETTING: Multicenter GWAS. Patients A total of 168 individuals with probable AD, 357 with mild cognitive impairment, and 215 cognitively normal control individuals recruited from more than 50 Alzheimer's Disease Neuroimaging Initiative centers in the United States and Canada. All study participants had APOE and genome-wide genetic data available. MAIN OUTCOME MEASURES: We investigated the influence of GWAS-validated and GWAS-promising novel AD loci on hippocampal volume, amygdala volume, white matter lesion volume, entorhinal cortex thickness, parahippocampal gyrus thickness, and temporal pole cortex thickness. RESULTS: Markers at the APOE locus were associated with all phenotypes except white matter lesion volume (all false discovery rate-corrected P values < .001). Novel and established AD loci identified by prior GWASs showed a significant cumulative score-based effect (false discovery rate P = .04) on all analyzed neuroimaging measures. The GWAS-validated variants at the CR1 and PICALM loci and markers at 2 novel loci (BIN1 and CNTN5) showed association with multiple magnetic resonance imaging characteristics (false discovery rate P < .05). CONCLUSIONS: Loci associated with AD also influence neuroimaging correlates of this disease. Furthermore, neuroimaging analysis identified 2 additional loci of high interest for further study.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
SNPs of BIN1, such as rs744373 and rs7561528, may contribute to AD susceptibility by impacting brain structure and function.
“In addition, the SNPs of BIN1, such as rs744373 and rs7561528, may contribute to AD susceptibility by impacting brain structure and function [480, 481].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [480]
SNPs in and around APOE, BIN1, SORL1, and CR1 have been associated with traits including medial temporal lobe atrophy and cortical thickness.
“SNPs in and around candidate genes including APOE, BIN1, SORL1, and CR1 have been associated with traits including medial temporal lobe atrophy and cortical thickness [225–228]”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [227]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · see citing works
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works
Cortical Surface-Based Analysis
Dale, A. M., Fischl, B., & Sereno, M. I. (1999) · NeuroImage · doi:10.1006/nimg.1998.0395 · Cited by 10,910 · see citing works
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882 · see citing works
Fischl, B., Salat, D. H., Busa, E., Albert, M., Dieterich, M., Haselgrove, C., van der Kouwe, A., Killiany, R., Kennedy, D., Klaveness, S., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)00569-x · Cited by 8,610 · see citing works
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864 · see citing works
Cortical Surface-Based Analysis
Fischl, B., Sereno, M. I., & Dale, A. M. (1999) · NeuroImage · doi:10.1006/nimg.1998.0396 · Cited by 6,147 · see citing works
Measuring the thickness of the human cerebral cortex from magnetic resonance images
Fischl, B. R., & Dale, A. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200033797 · Cited by 5,789 · see citing works
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326 · see citing works
More powerful procedures for multiple significance testing
Hochberg, Y., & Benjamini, Y. (1990) · Statistics in Medicine · doi:10.1002/sim.4780090710 · Cited by 2,715 · see citing works
Alzheimer's Disease Neuroimaging Initiative (ADNI)
Petersen, R. C., Aisen, P. S., Beckett, L. A., Donohue, M. C., Gamst, A. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Shaw, L. M., Toga, A. W., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181cb3e25 · Cited by 2,572 · see citing works
Peter, H., Penzel, T., Peter, J. H., & Peter, J. G. (2025) · Springer Reference Medizin · doi:10.1007/978-3-662-65186-5_302294 · Cited by 2,278 · see citing works
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234 · see citing works
Reynolds, C. R., & Powel, J. (1988) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/3.4.397 · Cited by 2,115 · see citing works
Purcell, S., Cherny, S. S., & Sham, P. C. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.1.149 · Cited by 2,057 · see citing works
The role of apolipoprotein E in Alzheimer's disease
Kim, J., Basak, J. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.026 · Cited by 1,661 · see citing works
Common variants at 30 loci contribute to polygenic dyslipidemia
Kathiresan, S., Willer, C. J., Peloso, G. M., Demissie, S., Musunuru, K., Schadt, E. E., Kaplan, L., Bennett, D., Li, Y., Tanaka, T., et al. (2009) · Nature Genetics · doi:10.1038/ng.291 · Cited by 1,364 · see citing works
Buckner, R. L., Head, D. M., Parker, J. B., Fotenos, A. F., Marcus, D. S., Morris, J. C., & Snyder, A. Z. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.06.018 · Cited by 1,290 · see citing works
Diagnostic and Statistical Manual of Mental Disorders
(2018) · Sage eBooks · doi:10.4135/9781506326139.n198 · Cited by 1,243 · see citing works
Genome-wide association study identifies eight loci associated with blood pressure
Wellcome Trust Case Control Consortium, Newton-Cheh, C., Johnson, T., Gateva, V., Tobin, M. D., Bochud, M., Coin, L., Najjar, S. S., Zhao, J. H., Heath, S. C., et al. (2009) · Nature Genetics · doi:10.1038/ng.361 · Cited by 1,215 · see citing works
Myocardial Infarction Genetics Consortium (2009) · Nature Genetics · doi:10.1038/ng.327 · Cited by 1,088 · see citing works
2009 Alzheimer's disease facts and figures
Alzheimer's Association (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.03.001 · Cited by 546 · see citing works
Genetic influences on human brain structure: A review of brain imaging studies in twins
Peper, J. S., Brouwer, R. M., Boomsma, D. I., Kahn, R. S., & Pol, H. E. H. (2007) · Human Brain Mapping · doi:10.1002/hbm.20398 · Cited by 429 · see citing works
Karas, G. B., Burton, E. J., Rombouts, S. A. R. B., van Schijndel, R. A., O'Brien, J. T., Scheltens, P., McKeith, I. G., Williams, D. M., Ballard, C. G., & Barkhof, F. (2003) · NeuroImage · doi:10.1016/s1053-8119(03)00041-7 · Cited by 418 · see citing works
Potkin, S. G., Guffanti, G., Lakatos, A., Turner, J. A., Kruggel, F., Fallon, J. H., Saykin, A. J., Orro, A., Lupoli, S., Salvi, E., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006501 · Cited by 376 · see citing works
Hippocampal atrophy rates in Alzheimer disease
Henneman, W. J. P., Sluimer, J. D., Barnes, J., van der Flier, W. M., Sluimer, I. C., Fox, N. C., Scheltens, P., Vrenken, H., & Barkhof, F. (2009) · Neurology · doi:10.1212/01.wnl.0000344568.09360.31 · Cited by 375 · see citing works
Butler, M. H., David, C., Ochoa, G.-C., Freyberg, Z., Daniell, L., Grabs, D., Cremona, O., & Camilli, P. D. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.137.6.1355 · Cited by 256 · see citing works
Genetics of Alzheimer's Disease: A Centennial Review
Ertekin‐Taner, N. (2007) · Neurologic Clinics · doi:10.1016/j.ncl.2007.03.009 · Cited by 233 · see citing works
Age, Alzheimer disease, and brain structure
Raji, C. A., López, O. L., Kuller, L. H., Carmichael, O. T., & Becker, J. T. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c3f293 · Cited by 230 · see citing works
The BAR Domain Proteins: Molding Membranes in Fission, Fusion, and Phagy
Ren, G., Vajjhala, P., Lee, J. S., Winsor, B., & Munn, A. (2006) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.70.1.37-120.2006 · Cited by 219 · see citing works
Voxel-based assessment of gray and white matter volumes in Alzheimer's disease
Guo, X., Wang, Z., Li, K., Li, Z., Qi, Z., Jin, Z. H., Yao, L., & Chen, K. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.10.086 · Cited by 164 · see citing works
Structural Analysis of the Human BIN1 Gene
Wechsler-Reya, R., Sakamuro, D., Zhang, J., Duhadaway, J., & Prendergast, G. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31453 · Cited by 142 · see citing works
Desikan, R. S., Cabral, H. J., Fischl, B., Guttmann, C. R. G., Blacker, D., Hyman, B. T., Albert, M. S., & Killiany, R. J. (2009) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1397 · Cited by 94 · see citing works
Appel, J., Potter, E. L., Bhatia, N. S., Shen, Q., Zhao, W., Greig, M. T., Raj, A., Barker, W., Potter, H., Schofield, E., et al. (2009) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1693 · Cited by 51 · see citing works
Kamei, Y., Takeda, Y., Teramoto, K., Tsutsumi, O., Taketani, Y., & Watanabe, K. (2000) · Genomics · doi:10.1006/geno.2000.6310 · Cited by 37 · see citing works
Potkin, S. G., Guffanti, G., Lakatos, A., Ja, T., Kruggel, F., Jh, F., Saykin, A. J., Orro, A., Lupoli, S., Salvi, E., et al. (2009) · UNICA IRIS Institutional Research Information System (University of Cagliari) · Cited by 34 · see citing works
Neuroimaging to assess safety and efficacy of AD therapies
Hill, D. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903381320 · Cited by 26 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Initiative, T. A. D. N., Hollingworth, P., CHARGE consortium, EADI1 consortium, Harold, D., Sims, R., Gerrish, A., Lambert, J.-C., Carrasquillo, M. M., Abraham, R., et al. (2011) · Nature Genetics · doi:10.1038/ng.803 · Cited by 1,997 · see citing works
Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis
Karch, C. M., & Goate, A. M. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.05.006 · Cited by 1,357 · see citing works
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
Guo, T., Zhang, D., Zeng, Y., Huang, T. Y., Xu, H., & Zhao, Y. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00391-7 · Cited by 994 · see citing works
The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception
Weiner, M. W., Veitch, D. P., Aisen, P. S. S., Beckett, L. A., Cairns, N. J., Green, R. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Liu, E., et al. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.05.1769 · Cited by 1,011 · see citing works
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data
the Alzheimer’s Disease Neuroimaging Initiative, E. C., Thompson, P. M., Stein, J. L., Medland, S. E., Hibar, D. P., Vasquez, A. A., Renteria, M. E., Toro, R., Jahanshad, N., Schumann, G., et al. (2014) · Brain Imaging and Behavior · doi:10.1007/s11682-013-9269-5 · Cited by 838 · see citing works
The multiplex model of the genetics of Alzheimer's disease
Sims, R., Hill, M., & Williams, J. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0599-5 · Cited by 466 · see citing works
The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception
Weiner, M. W., Veitch, D. P., Aisen, P. S. S., Beckett, L. A., Cairns, N. J., Green, R. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Liu, E., et al. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.09.172 · Cited by 477 · see citing works
Alzheimer’s Disease Genetics: From the Bench to the Clinic
Karch, C. M., Cruchaga, C., & Goate, A. M. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.041 · Cited by 473 · see citing works
Clusterin in Alzheimer’s Disease: Mechanisms, Genetics, and Lessons From Other Pathologies
Foster, E. M., Dangla-Valls, A., Lovestone, S., Ribe, E. M., & Buckley, N. J. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00164 · Cited by 381 · see citing works
Nelson, P. T., Head, E., Schmitt, F. A., Davis, P. R., Neltner, J. H., Jicha, G. A., Abner, E. L., Smith, C. D., Van Eldik, L. J., Kryscio, R. J., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0826-y · Cited by 365 · see citing works
Weiner, M. W., Veitch, D. P., Aisen, P. S., Beckett, L. A., Cairns, N. J., Cedarbaum, J., Green, R. C., Harvey, D., Jack, C. R., Jagust, W., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.11.001 · Cited by 348 · see citing works
Doens, D., & Fernández, P. L. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-48 · Cited by 348 · see citing works
Genetic insights in Alzheimer's disease
Bettens, K., Sleegers, K., & Broeckhoven, C. V. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70259-4 · Cited by 326 · see citing works
Alzheimer’s disease: analyzing the missing heritability
Ridge, P. G., Mukherjee, S., Crane, P. K., Kauwe, J. S. K., & Alzheimer’s Disease Genetics Consortium (2013) · PLoS ONE · doi:10.1371/journal.pone.0079771 · Cited by 328 · see citing works
Genes associated with Alzheimer&#39;s disease: an overview and current status
Giri, M., Lü, Y., & Zhang, M. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s105769 · Cited by 311 · see citing works
Variants at APOE influence risk of deep and lobar intracerebral hemorrhage
Biffi, A., Sonni, A., Anderson, C. D., D, B. M. K. M., Jagiella, J. M., Schmidt, H., Jiménez-Conde, J., Hansen, B. M., Fernández‐Cadenas, I., Cortellini, L., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22134 · Cited by 278 · see citing works
Self-citationZhou, T., Thung, K., Zhu, X., & Shen, D. G. (2018) · Human Brain Mapping · doi:10.1002/hbm.24428 · Cited by 270 · see citing works
A Comprehensive Genetic Association Study of Alzheimer Disease in African Americans
Logue, M. W. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.646 · Cited by 250 · see citing works
Assessment of the genetic variance of late-onset Alzheimer's disease
Ridge, P. G., Hoyt, K. B., Boehme, K., Mukherjee, S., Crane, P. K., Haines, J. L., Mayeux, R., Farrer, L. A., Pericak-Vance, M. A., Schellenberg, G. D., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.02.024 · Cited by 236 · see citing works
Genetics of Alzheimer’s Disease
Chouraki, V. A., & Seshadri, S. S. (2014) · Advances in genetics · doi:10.1016/b978-0-12-800149-3.00005-6 · Cited by 208 · see citing works
A genome-wide scan for common variants affecting the rate of age-related cognitive decline
Jager, P. L. D., Shulman, J. M., Chibnik, L. B., Keenan, B. T., Raj, T., Wilson, R. S., Yu, L., Leurgans, S. E., Tran, D., Aubin, C., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.033 · Cited by 192 · see citing works
Self-citationBridging integrator 1 (BIN1): form, function, and Alzheimer's disease
Tan, M., Yu, J., & Tan, L. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.06.004 · Cited by 187 · see citing works
Genomic variants, genes, and pathways of Alzheimer's disease: An overview
Naj, A. C., & Schellenberg, G. D. (2016) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32499 · Cited by 178 · see citing works
Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers
Initiative, A. D. N., Shen, L., Thompson, P. M., Potkin, S. G., Bertram, L., Farrer, L. A., Foroud, T., Green, R. C., Hu, X., Huentelman, M. J., et al. (2013) · Brain Imaging and Behavior · doi:10.1007/s11682-013-9262-z · Cited by 174 · see citing works
APOE genotype and MRI markers of cerebrovascular disease
Schilling, S., DeStefano, A. L., Sachdev, P. S., Choi, S. H., Mather, K. A., DeCarli, C. S., Wen, W. X., Høgh, P., Raz, N., Au, R., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31829bfda4 · Cited by 171 · see citing works
Braskie, M. N., Jahanshad, N., Stein, J. L., Marina Barysheva, A., McMahon, K. L., de Zubicaray, G. I., Martin, N. G., Wright, M. J., Ringman, J. M., Toga, A. W., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.5794-10.2011 · Cited by 170 · see citing works
Common Variants in Psychiatric Risk Genes Predict Brain Structure at Birth
Knickmeyer, R. C., Wang, J., Zhu, H., Geng, X., Woolson, S., Hamer, R. M., Konneker, T., Lin, W., Styner, M., & Gilmore, J. H. (2014) · Cerebral Cortex · doi:10.1093/cercor/bhs401 · Cited by 149 · see citing works
Tan, L., Yu, J., Zhang, W., Wu, Z., Zhang, Q., Liu, Q., Wang, W., Wang, H.-F., Ma, X., & Cui, W. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.08.007 · Cited by 146 · see citing works
Complement receptor 1 (CR1) and Alzheimer's disease
Crehan, H., Holton, P., Wray, S., Pocock, J., Guerreiro, R., & Hardy, J. (2012) · Immunobiology · doi:10.1016/j.imbio.2011.07.017 · Cited by 129 · see citing works
Sabuncu, M. R., Buckner, R. L., Smoller, J. W., Lee, P. H., Fischl, B. R., & Sperling, R. A. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhr348 · Cited by 130 · see citing works
The genetic landscape of Alzheimer disease
Carmona, S., Hardy, J., & Guerreiro, R. J. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64076-5.00026-0 · Cited by 133 · see citing works
Regional white matter hyperintensities: aging, Alzheimer's disease risk, and cognitive function
Birdsill, A. C., Koscik, R. L., Jonaitis, E. M., Johnson, S. C., Okonkwo, O. C., Hermann, B. P., LaRue, A. A., Sager, M. A., & Bendlin, B. B. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.10.072 · Cited by 126 · see citing works
The effect of increased genetic risk for Alzheimer's disease on hippocampal and amygdala volume
Lupton, M. K., Strike, L. T., Hansell, N. K., Wen, W. X., Mather, K. A., Armstrong, N. J., Thalamuthu, A., McMahon, K. L., de Zubicaray, G. I., Assareh, A. A., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.12.023 · Cited by 120 · see citing works
Genetic architecture of Alzheimer's disease
Neuner, S. M., TCW, J., & Goate, A. M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104976 · Cited by 126 · see citing works
Genome-wide association study of Alzheimer's disease with psychotic symptoms
Hollingworth, P., Sweet, R. A., Sims, R., Harold, D. H., Russo, G., Abraham, R., Stretton, A., Jones, N., Gerrish, A., Chapman, J., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.125 · Cited by 123 · see citing works
Meda, S. A., Narayanan, B., Liu, J., Perrone‐Bizzozero, N. I., Stevens, M. C. G., Calhoun, V. D., Glahn, D. C., Shen, L., Risacher, S. L., Saykin, A. J., et al. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.12.076 · Cited by 119 · see citing works
The Role of PICALM in Alzheimer’s Disease
Xu, W., Tan, L., & Yu, J. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8878-3 · Cited by 119 · see citing works
Associations of the Top 20 Alzheimer Disease Risk Variants With Brain Amyloidosis
Apostolova, L. G., Risacher, S. L., Duran, T., Stage, E., Goukasian, N., West, J. D., Do, T. M., Grotts, J. F., Wilhalme, H. M., Nho, K. T., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2017.4198 · Cited by 122 · see citing works
The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory
Franzmeier, N., Rubinski, A., Neitzel, J., Ewers, M., (ADNI), T. A. D. N. I., Weiner, M. W., Aisen, P., Petersen, R., Jack, C. R., Jagust, W., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09564-5 · Cited by 109 · see citing works
Stilling, R. M., Benito, E., Barth, J., Gertig, M., Capece, V., Burckhardt, S., Bonn, S., & Fischer, A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00373 · Cited by 116 · see citing works
Devan, W. J., Falcone, G. J., Anderson, C. D., Jagiella, J. M., Schmidt, H., Hansen, B. M., Jiménez-Conde, J., Steinhauer, E. G., Cuadrado‐Godia, E., Soriano‐Tárraga, C., et al. (2013) · Stroke · doi:10.1161/strokeaha.111.000089 · Cited by 110 · see citing works
Self-citationAlzheimer's Disease Risk Assessment Using Large-Scale Machine Learning Methods
Casanova, R., Hsu, F., Sink, K. M., Rapp, S. R., Williamson, J. D., Resnick, S. M., Espeland, M. A., & Initiative, A. D. N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077949 · Cited by 107 · see citing works
The Declining Infrastructure of the Aging Brain
Salat, D. H. (2011) · Brain Connectivity · doi:10.1089/brain.2011.0056 · Cited by 105 · see citing works
PICALM and Alzheimer’s Disease: An Update and Perspectives
Ando, K., Nagaraj, S., Küçükali, F., de Fisenne, M.-A., Kosa, A.-C., Doeraene, E., Lopez Gutierrez, L., Brion, J.-P., & Leroy, K. (2022) · Cells · doi:10.3390/cells11243994 · Cited by 104 · see citing works
Genotype patterns atPICALM, CR1, BIN1, CLU, andAPOEgenes are associated with episodic memory
Barral, S., Bird, T. D., Goate, A., Farlow, M. R., Diaz-Arrastia, R. R., Bennett, D. A. A., Graff‐Radford, N. R., Boeve, B. F., Sweet, R. A., Stern, Y., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182553c48 · Cited by 103 · see citing works
Association of Alzheimer's disease GWAS loci with MRI markers of brain aging
Chauhan, G., Adams, H. H. H., Bis, J. C., Weinstein, G., Yu, L., Töglhofer, A. M., Smith, A. V., van der Lee, S. J., Gottesman, R. F., Thomson, R. J., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.12.028 · Cited by 95 · see citing works
Foley, S. F., Tansey, K. E., Caseras, X., Lancaster, T. M., Bracht, T., Parker, G. D., Hall, J., Williams, J. H., & Linden, D. E. J. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.02.033 · Cited by 95 · see citing works
Evaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer’s Disease
Chouraki, V., for the International Genomics of Alzheimer’s Project, Reitz, C., Maury, F., Bis, J. C., Bellenguez, C., Yu, L., Jakobsdottir, J., Mukherjee, S., Adams, H. H., et al. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150749 · Cited by 98 · see citing works
Genetic variation at CR1 increases risk of cerebral amyloid angiopathy
Biffi, A., Shulman, J. M., Jagiella, J. M., Cortellini, L., Ayres, A. M., Schwab, K. M., Brown, D. L., Silliman, S. L., Selim, M. H., Worrall, B. B., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182452b40 · Cited by 97 · see citing works
Self-citationStocker, H. R., Möllers, T., Perna, L., & Brenner, H. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0221-8 · Cited by 96 · see citing works
Genetics of Alzheimer’s Disease
Ridge, P. G., Ebbert, M., & Kauwe, J. S. K. (2013) · BioMed Research International · doi:10.1155/2013/254954 · Cited by 96 · see citing works
An Overview of Genome-Wide Association Studies in Alzheimer’s Disease
Shen, L., & Jia, J. (2016) · Neuroscience Bulletin · doi:10.1007/s12264-016-0011-3 · Cited by 90 · see citing works
A coding variant in CR1 interacts with APOE-ɛ4 to influence cognitive decline
Keenan, B. T., Shulman, J. M., Chibnik, L. B., Raj, T., Tran, D., Sabuncu, M. R., Initiative, T. A. D. N., Allen, A. N., Corneveaux, J. J., Hardy, J., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds054 · Cited by 93 · see citing works
Silver, M. J., Janoušová, E., Hua, X., Thompson, P. M., & Montana, G. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.08.002 · Cited by 86 · see citing works
Zhu, X., Yu, J., Jiang, T., Wang, P., Cao, L., & Tan, L. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8723-8 · Cited by 84 · see citing works
Microglia, Alzheimer's Disease, and Complement
Crehan, H., Hardy, J., & Pocock, J. M. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/983640 · Cited by 84 · see citing works
Genome-wide analysis of genetic predisposition to Alzheimer’s disease and related sex disparities
Nazarian, A., Yashin, A. I., & Kulminski, A. M. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0458-8 · Cited by 80 · see citing works
Watanabe, T., Hikichi, Y., Willuweit, A., Shintani, Y., & Horiguchi, T. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5659-11.2012 · Cited by 75 · see citing works
Lyall, D. M., Harris, S. E., Bastin, M. E., Maniega, S. M., Murray, C. L., Lutz, M. W., Saunders, A. M., Roses, A. D., Hernández, M. D. C. V., Royle, N. A., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.006 · Cited by 71 · see citing works
Complement activation as a biomarker for Alzheimer's disease
Aiyaz, M., Lupton, M. K., Proitsi, P., Powell, J. F., & Lovestone, S. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.07.023 · Cited by 69 · see citing works
Marini, S., Crawford, K., Morotti, A., Lee, M. J., Pezzini, A., Moomaw, C. J., Flaherty, M. L., Montaner, J., Roquer, J., Jimenez-Conde, J., et al. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2018.4519 · Cited by 68 · see citing works
Self-citationHarrison, T. M., Mahmood, Z., Lau, E., Karacozoff, A. M., Burggren, A., Small, G., & Bookheimer, S. (2016) · eNeuro · doi:10.1523/eneuro.0098-16.2016 · Cited by 67 · see citing works
Evaluation of late-onset Alzheimer disease genetic susceptibility risks in a Canadian population
Omoumi, A., Fok, A., Greenwood, T., Sadovnick, A. D., Feldman, H., & Hsiung, G. R. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.025 · Cited by 64 · see citing works
Tan, L., Wang, H.-F., Tan, M., Tan, C., Zhu, X., Miao, D., Yu, W.-J., Jiang, T., Tan, L., Yu, J., et al. (2016) · Scientific Reports · doi:10.1038/srep26027 · Cited by 63 · see citing works
Genetic Analysis of Cortical Thickness and Fractional Anisotropy of Water Diffusion in the Brain
Kochunov, P., Glahn, D. C., Nichols, T. E., Winkler, A. M., Hong, E. L., Holcomb, H. H., Stein, J. L., Thompson, P. M., Curran, J. E., Carless, M. A., et al. (2011) · Frontiers in Neuroscience · doi:10.3389/fnins.2011.00120 · Cited by 61 · see citing works
From Polygenic Scores to Precision Medicine in Alzheimer’s Disease: A Systematic Review
Harrison, J. R., Mistry, S., Muskett, N., & Escott‐Price, V. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191233 · Cited by 61 · see citing works
Replication of BIN1 Association with Alzheimer's Disease and Evaluation of Genetic Interactions
Carrasquillo, M. M., Belbin, O., Hunter, T. A., Ma, L., Bisceglio, G. D., Zou, F., Crook, J. E., Pankratz, V. S., Sando, S. B., Aasly, J. O., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101932 · Cited by 60 · see citing works
Neuroimaging Measures as Endophenotypes in Alzheimer′s Disease
Braskie, M. N., Ringman, J. M., & Thompson, P. M. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/490140 · Cited by 58 · see citing works
A genome-wide association study of brain lesion distribution in multiple sclerosis
Gourraud, P., Sdika, M., Khankhanian, P., Henry, R. G., Beheshtian, A., Matthews, P. M., Hauser, S. L., Oksenberg, J. R., Pelletier, D., & Baranzini, S. E. (2013) · Brain · doi:10.1093/brain/aws363 · Cited by 56 · see citing works
Olgiati, P., Politis, A. M., Papadimitriou, G. N., Ronchi, D. D., & Serretti, A. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/832379 · Cited by 57 · see citing works
Porter, T., Burnham, S. C., Milicic, L., Savage, G. R., Maruff, P. T., Lim, Y. Y., Li, Q.-X., Ames, D. J., Masters, C. L., Rainey‐Smith, S. R., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180713 · Cited by 56 · see citing works
Wang, H.-F., Alzheimer’s, D. N. I., Wan, Y., Hao, X., Cao, L., Zhu, X., Jiang, T., Tan, M., Tan, L., Zhang, D., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150972 · Cited by 55 · see citing works
Dong, H. K., Gim, J., Yeo, S. H., & Kim, H. (2016) · Gene · doi:10.1016/j.gene.2016.10.022 · Cited by 54 · see citing works
Zhang, X., Yu, J., Li, J., Wang, C., Tan, L., Liu, B., & Jiang, T. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.30 · Cited by 53 · see citing works
A Longitudinal Imaging Genetics Study of Neuroanatomical Asymmetry in Alzheimer’s Disease
Wachinger, C., Nho, K. T., Saykin, A. J., Reuter, M., & Rieckmann, A. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.04.017 · Cited by 53 · see citing works
Modifiable cardiovascular risk factors and genetics for targeted prevention of dementia
Rasmussen, I. J., & Frikke‐Schmidt, R. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad293 · Cited by 54 · see citing works
A Focus on Structural Brain Imaging in the Alzheimer’s Disease Neuroimaging Initiative
Braskie, M. N., & Thompson, P. M. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.11.020 · Cited by 51 · see citing works
DNA methylation in neurodegenerative disorders: a missing link between genome and environment?
Iraola‐Guzmán, S., Estivill, X., & Rabionet, R. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2011.01673.x · Cited by 52 · see citing works
Su, F., Shu, H., Ye, Q., Wang, Z., Xie, C., Yuan, B., Zhang, Z., & Bai, F. (2016) · NeuroImage Clinical · doi:10.1016/j.nicl.2016.12.009 · Cited by 52 · see citing works
Predicting white matter integrity from multiple common genetic variants
Kohannim, O., Jahanshad, N., Braskie, M. N., Stein, J. L., Chiang, M.-C., Reese, A. H., Hibar, D. P., Toga, A. W., McMahon, K. L., de Zubicaray, G. I., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.49 · Cited by 50 · see citing works
Mirabnahrazam, G., Initiative, T. A. D. N., Ma, D., Lee, S., Popuri, K., Lee, H., Cao, J., Wang, L., Galvin, J. E., & Beg, M. F. (2022) · Journal of Alzheimer's Disease · doi:10.3233/jad-220021 · Cited by 50 · see citing works
Common variants in ABCA7 and MS4A6A are associated with cortical and hippocampal atrophy
Ramirez, L. M., Goukasian, N., Porat, S., Hwang, K., Eastman, J. A., Hurtz, S., Wang, B., Vang, N., Sears, R., Klein, E., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.10.037 · Cited by 49 · see citing works
HENA, heterogeneous network-based data set for Alzheimer’s disease
Sügis, E., Dauvillier, J., Leontjeva, A., Adler, P., Hindie, V., Moncion, T., Collura, V., Daudin, R., Loe-Mie, Y., Hérault, Y., et al. (2019) · Scientific Data · doi:10.1038/s41597-019-0152-0 · Cited by 50 · see citing works
Impact of late-onset Alzheimer’s genetic risk factors on beta-amyloid endocytic production
Almeida, C. G., Mirfakhar, F. S., Perdigão, C., & Burrinha, T. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2825-9 · Cited by 48 · see citing works
Stage, E., Duran, T., Risacher, S. L., Goukasian, N., Do, T. M., West, J. D., Wilhalme, H. M., Nho, K. T., Phillips, M. L., Elashoff, D. A., et al. (2016) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.12.003 · Cited by 49 · see citing works
Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load
Grothe, M. J., Villeneuve, S., Dyrba, M., David Bartrés-faz, A., Wirth, M., Initiative, A. D. N., Initiative, A. D. N., Weiner, M. W., Aisen, P., Weiner, M. W., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000003585 · Cited by 47 · see citing works
Grünblatt, E., Hauser, T. U., & Walitza, S. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.07.003 · Cited by 44 · see citing works
Alzheimer’s Disease: From Genetic Variants to the Distinct Pathological Mechanisms
Sun, Q., Xie, N., Tang, B., Li, R., & Shen, Y. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00319 · Cited by 46 · see citing works
A Deep Generative–Discriminative Learning for Multimodal Representation in Imaging Genetics
Ko, W., Jung, W., Jeon, E., & Suk, H. (2022) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2022.3162870 · Cited by 44 · see citing works
Structural Neuroimaging Genetics Interactions in Alzheimer’s Disease
Moon, S. W., Dinov, I. D., Kim, J., Zamanyan, A., Hobel, S., Thompson, P. M., Toga, A. W., & Initiative, A. F. T. A. D. N. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150335 · Cited by 43 · see citing works
State of Play in Alzheimer’s Disease Genetics
Zhu, J.-B., Tan, C., Tan, L., & Yu, J. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170062 · Cited by 43 · see citing works
Whitehouse, I. J., Miners, J. S., Glennon, E. B. C., Kehoe, P. G., Love, S., Kellett, K. A. B., & Hooper, N. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059554 · Cited by 43 · see citing works
A review of brain imaging biomarker genomics in Alzheimer’s disease: implementation and perspectives
Li, L., Yu, X., Sheng, C., Jiang, X., Zhang, Q., Han, Y., & Jiang, J. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00315-z · Cited by 40 · see citing works
Neural hyperactivation in carriers of the Alzheimer's risk variant on the clusterin gene
Lancaster, T. M., Baird, A. L., Wolf, C., Jackson, M. C., Johnston, S. J., Donev, R., Thome, J., & Linden, D. E. J. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.02.001 · Cited by 40 · see citing works
Liu, Y., Yu, J., Wang, H.-F., Hao, X., Yang, Y.-F., Jiang, T., Zhu, X., Cao, L., Zhang, D., & Tan, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114777 · Cited by 39 · see citing works
CR1 genotype is associated with entorhinal cortex volume in young healthy adults
Bralten, J., Franke, B., Vásquez, A. A., Heister, A. J. G. A. M., Brunner, H. G., Fernández, G., & Rijpkema, M. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.05.017 · Cited by 39 · see citing works
Neuroinflammatory Cytokines - The Common Thread in Alzheimer Pathogenesis
Griffin, W. S. T., Barger, S. W., & Chairman, D. P. A. V. (2011) · European Neurological Review · doi:10.17925/enr.2011.06.02.89 · Cited by 39 · see citing works
Arefin, A. S., Mathieson, L., Johnstone, D. M., Berretta, R. E., & Moscato, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045535 · Cited by 39 · see citing works
Porter, T., Burnham, S. C., Savage, G. R., Lim, Y. Y., Maruff, P. T., Milicic, L., Peretti, M., Ames, D. J., Masters, C. L., Martins, R. N., et al. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00423 · Cited by 37 · see citing works
Imaging epigenetics in Alzheimer's disease.
Lista, S., Garaci, F., Toschi, N., & Hampel, H. (2013) · Current pharmaceutical design · doi:10.2174/13816128113199990370 · Cited by 37 · see citing works
- Authors
- Biffi, A.
- Affiliations
- Massachusetts General Hospital (US)
- Corresponding author
- Biffi, Alessandro
- ORCID
- Biffi, Alessandro
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2010-06-01
- Volume
- 67
- Issue
- 6
- Pages
- 677
- ISSN
- 0003-9942 (ISSN-L)
- PMC
- PMC2956757
- OpenAlex
- W2105172870
- Cited by
- 222
- References
- 36
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 6 · 2023: 5 · 2022: 12 · 2021: 9 · 2020: 14 · 2019: 17 · 2018: 14 · 2017: 9 · 2016: 28 · 2015: 14 · 2014: 19 · 2013: 26 · 2012: 14
- FWCI
- 14.83
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Archives of Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Foundation for the National Institutes of Health (U01AG024904, AG024904)
- Howard Hughes Medical Institute
- Ellison Medical Foundation
- Alzheimer's Association (AG05681, U01 AG024904)
- American Heart Association
- Bristol-Myers Squibb (U01 AG024904, AG024904)
- Eli Lilly and Company (U01 AG024904, AG024904)
- Pfizer (AG024904, U01 AG024904)
- GlaxoSmithKline (P01AG03991)
- Northern California Institute for Research and Education (U01 AG024904)
- Elan (U01 AG024904)
- Eisai (U01 AG024904, AG024904)
- National Institutes of Health (5u01ag024904-10, 6u54rr020278-06, BIRN002, U01-AG024904, AG05681, RR14075, AG024904, NS042861)
- University of California, Los Angeles
- University of California, San Diego
- National Institute on Aging (U01-AG-024904, AG021910, P30AG010129, R01AG021910, R01AG026484, AG 024904, K01AG030514, AG 05681, P 50 AG05681, P50AG005681, P01 AG0 3991, P01AG003991, AG02238, U19AG010483, U24AG021886)
- National Institute on Drug Abuse (R21DA026104)
- National Institute of Neurological Disorders and Stroke (R01NS042861, R01NS059727, R01NS052585)
- National Institute of Biomedical Imaging and Bioengineering (R01EB001550, R01EB006758, U01 AG024904, AG024904)
- National Center for Research Resources (U54-RR020278, P41-RR-14075, RR 14075, U24RR021382, R01 RR1659401A1, P41RR014075, BIRN002, R01RR016594, U01 AG024904)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- Alzheimer's disease, genetic loci, genome-wide association study, hippocampal volume, amygdala volume, white matter lesions, cortical thickness, apolipoprotein E, complement receptor 1, PICALM, BIN1, CNTN5, mild cognitive impairment, Alzheimer's Disease Neuroimaging Initiative
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Apolipoproteins E, Canada, Cognition Disorders, Female, Genotype, Humans, Image Interpretation, Computer-Assisted, Magnetic Resonance Imaging, Male, Neuropsychological Tests, Nuclear Proteins, Risk Factors, United States, Reproducibility of Results, Cell Adhesion Molecules, Neuronal, Logistic Models, Odds Ratio, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Tumor Suppressor Proteins, Adaptor Proteins, Signal Transducing, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review